Search Results 101-110 of 16276 for monoclonal antibody

1. Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation - Mayo Clinic

   Denosumab is a monoclonal antibody that is used to treat bone loss in order to reduce the risk of bone fractures in healthy people, and to reduce new bone ...

2. Belimumab (intravenous route, subcutaneous route) - Mayo Clinic

   Belimumab injection is used to treat active, autoantibody ... It is a monoclonal antibody that changes the immune system to help control lupus symptoms.

3. Strategy for Improving Stroke Treatment Response - Mayo Clinic

   The purpose of this study is to determine the safety and preliminary efficacy of TS23, a monoclonal antibody against the alpha-2 antiplasmin (a2-AP), in ...

4. Cancer to COVID-19: Experimental treatment pivots in record time - Mayo Clinic News Network

   But then the pandemic started. Literature Lightbulb. Lenzilumab is a monoclonal antibody drug. Read more about monoclonal antibodies in, "Monoclonal Antibodies: ...

5. Study of ACTR087 in Combination With SEA-BCMA in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   ... monoclonal antibody) in subjects with relapsed or refractory Multiple Myeloma. Participation eligibility. Participant eligibility includes age, gender, type ...

6. Belantamab, Lenalidomide, and Daratumumab for Newly-diagnosed Multiple Myeloma - Mayo Clinic

   Daratumumab is a drug that is a monoclonal antibody that is directed towards a protein on the myeloma cell. The proposed belantamab-mafodotin combinations ...

7. Hong Qin, M.D., Ph.D. - Mayo Clinic Faculty Profiles

   Qin's antibody discovery research is focused on developing monoclonal antibodies against both well‐characterized and unknown antigens. To accomplish the former ...

8. Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic

   ... monoclonal antibody therapy prior to anti-EGFR monoclonal antibody therapy. For those with left-sided tumors, the data are less clear. However, we at least ...

9. A Safety and Efficacy Study of Domvanalimab + Zimberelimab Combination Therapy in Participants With Advanced Upper Gastrointestinal Tract Malignancies - Mayo Clinic

   ... monoclonal antibody domvanalimab, the anti-programmed cell death protein 1 (PD-1) monoclonal antibody zimberelimab, and multiagent chemotherapy in the first ...

10. Ixekizumab in the Treatment of Bullous Pemphigoid - Mayo Clinic

    Ixekizumab is a recombinant high-affinity fully human monoclonal antibody that targets IL-17A Immunoglobulin gamma-1 (IgG1)/kappa-class. The purpose of this ...